CREB3L2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.170600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.444000E-01
Normal-vs-Stage2
8.412400E-01
Normal-vs-Stage3
2.345000E-01
Normal-vs-Stage4
7.130600E-01
Stage1-vs-Stage2
7.474400E-01
Stage1-vs-Stage3
4.874000E-02
Stage1-vs-Stage4
8.435200E-01
Stage2-vs-Stage3
1.338590E-01
Stage2-vs-Stage4
5.892000E-01
Stage3-vs-Stage4
2.486600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.213400E-01
Normal-vs-AfricanAmerican
3.402800E-01
Normal-vs-Asian
5.703000E-01
Caucasian-vs-AfricanAmerican
1.939770E-01
Caucasian-vs-Asian
1.391170E-01
AfricanAmerican-vs-Asian
4.605900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.525800E-01
Normal-vs-Female
7.624000E-01
Male-vs-Female
7.064600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.932600E-01
Normal-vs-Age(41-60Yrs)
4.423000E-01
Normal-vs-Age(61-80Yrs)
9.504800E-01
Normal-vs-Age(81-100Yrs)
5.760800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.624400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.601000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.605200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.700000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.040400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.808380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.722800E-01
Normal-vs-Daily Drinker
7.253600E-01
Normal-vs-Weekly Drinker
7.350400E-01
Normal-vs-Occasional Drinker
8.829400E-01
Normal-vs-Social Drinker
4.149600E-01
Non Drinker-vs-Daily Drinker
8.181000E-01
Non Drinker-vs-Weekly Drinker
8.999800E-02
Non Drinker-vs-Occasional Drinker
1.832390E-01
Non Drinker-vs-Social Drinker
2.117800E-02
Daily Drinker-vs-Weekly Drinker
2.104600E-01
Daily Drinker-vs-Occasional Drinker
3.486000E-01
Daily Drinker-vs-Social Drinker
2.372400E-02
Weekly Drinker-vs-Occasional Drinker
7.167400E-01
Weekly Drinker-vs-Social Drinker
3.464200E-01
Occasional Drinker-vs-Social Drinker
1.722000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.752000E-01
Normal-vs-Grade 2
8.603800E-01
Normal-vs-Grade 3
8.996600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.307400E-01
Grade 1-vs-Grade 3
6.999400E-01
Grade 1-vs-Grade 4
6.752000E-01
Grade 2-vs-Grade 3
5.231200E-01
Grade 2-vs-Grade 4
8.603800E-01
Grade 3-vs-Grade 4
8.996600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.510600E-01
Normal-vs-NonDiabetic
9.585000E-01
Diabetic-vs-NonDiabetic
9.566000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.894800E-01
Normal-vs-NoPancreatitis
9.489000E-01
Pancreatitis-vs-NoPancreatitis
7.107200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.446200E-01
Normal-vs-N1
8.179400E-01
N0-vs-N1
9.590800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.701200E-01
Normal-vs-TP53-NonMutant
6.885000E-01
TP53-Mutant-vs-TP53-NonMutant
5.436400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
